Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.

@article{Shmueli2013CosteffectivenessOB,
  title={Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.},
  author={Amir Shmueli and Shifra Fraifeld and Tamar Peretz and Orit Gutfeld and Maya Gips and Jacob Sosna and Dorith Shaham},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2013},
  volume={16 6},
  pages={922-31}
}
OBJECTIVE Reduced mortality with low-dose computed tomography (LDCT) lung cancer screening was demonstrated in a large randomized controlled study of high-risk individuals. Cost-effectiveness must be assessed before routine LDCT screening is considered. We aimed to evaluate the cost-effectiveness of LDCT lung cancer screening in Israel. METHODS A decision analytic framework was used to evaluate the decision to screen or not screen from the health system perspective. The screening arm included… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…